Cited 0 time in
Primary effusion lymphoma with biphenotypic and bigenotypic features of T-cell receptor and IGH genes in an HIV-negative patient with kidney transplant
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jeon, Taesung | - |
| dc.contributor.author | Ko, Young-hyeh | - |
| dc.contributor.author | Sung, You-na | - |
| dc.contributor.author | Kim, Hyunsung | - |
| dc.contributor.author | Kang, Ka-won | - |
| dc.contributor.author | Sim, Jongmin | - |
| dc.contributor.author | Kim, Yeseul | - |
| dc.date.accessioned | 2025-11-27T02:30:36Z | - |
| dc.date.available | 2025-11-27T02:30:36Z | - |
| dc.date.issued | 2025-10 | - |
| dc.identifier.issn | 0939-5555 | - |
| dc.identifier.issn | 1432-0584 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/209360 | - |
| dc.description.abstract | Primary effusion lymphoma (PEL) is a rare and aggressive non-Hodgkin lymphoma that primarily involves body cavities and is characterized by human herpes virus-8 (HHV-8) positivity and the presence of immunoblastic, plasmablastic or anaplastic cells. PEL typically lacks B-cell antigens, but involves immunoglobulin gene rearrangements, suggesting a B-cell origin. Here, we present a highly unusual case of PEL in which tumor cells expressed T-cell antigens but were also monoclonal for both T-cell receptor (TCR) and immunoglobulin heavy locus (IGH) gene rearrangements. An 81-year-old man with bilateral pleural effusions presented with atypical lymphoid cells. Immunohistochemistry revealed positivity for CD3, CD4, MUM-1, OCT2, BOB1, and HHV-8, but negativity for other T- and B-cell antigens. In situ hybridization identified Epstein-Barr virus and lambda light chain restriction. Gene rearrangement studies demonstrated monoclonal TRB (T-cell receptor beta locus) and TRG (T-cell receptor gamma locus) as well as IGH rearrangement. This unusual case of PEL with T-cell antigen expression and clonal rearrangement of both the TCR and IGH genes highlights the lineage complexity of this tumor. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Springer Verlag | - |
| dc.title | Primary effusion lymphoma with biphenotypic and bigenotypic features of T-cell receptor and IGH genes in an HIV-negative patient with kidney transplant | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1007/s00277-025-06396-w | - |
| dc.identifier.scopusid | 2-s2.0-105016730403 | - |
| dc.identifier.wosid | 001575976300001 | - |
| dc.identifier.bibliographicCitation | Annals of Hematology, v.104, no.10, pp 5513 - 5519 | - |
| dc.citation.title | Annals of Hematology | - |
| dc.citation.volume | 104 | - |
| dc.citation.number | 10 | - |
| dc.citation.startPage | 5513 | - |
| dc.citation.endPage | 5519 | - |
| dc.type.docType | Article in press | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Hematology | - |
| dc.relation.journalWebOfScienceCategory | Hematology | - |
| dc.subject.keywordPlus | B-CELL | - |
| dc.subject.keywordPlus | ABERRANT EXPRESSION | - |
| dc.subject.keywordPlus | CD3 | - |
| dc.subject.keywordPlus | REARRANGEMENTS | - |
| dc.subject.keywordAuthor | Primary effusion lymphoma | - |
| dc.subject.keywordAuthor | Biphenotypic | - |
| dc.subject.keywordAuthor | Bigenotypic | - |
| dc.subject.keywordAuthor | EBV-positive | - |
| dc.subject.keywordAuthor | HIV-negative | - |
| dc.subject.keywordAuthor | Lineage infidelity | - |
| dc.identifier.url | https://link.springer.com/article/10.1007/s00277-025-06396-w | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
